In the 3xTg mouse model of AD, Ezra et al. showed that intraventricular infusion of synthetic serum albumin for 28 days, using an osmotic pump, led to a decrease of both Aβ monomers and oligomers in brain homogenates and amyloid plaques in histological samples (48). This evidence concerns the gene ALB and Alzheimer disease.